{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:53:18Z","timestamp":1793404398569,"version":"4.5.0"},"reference-count":22,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>The reactivation of latent Leishmania infection in chronic diseases and immunocompromised hosts is a broad and heterogeneous field in medicine and infectious diseases. We reported one of the first cases of Visceral Leishmaniasis occurring in a Caucasian middle-aged man living in an endemic country (Italy) for Leishmania infantum infection following secukinumab treatment for psoriatic arthritis. The patient was cured with a Liposomal Amphotericin B (L-AmB, 3 mg\/Kg on days 1\u20135, followed by a dose on days 10, 17, 24, 31 and 38) regimen, after which his anti-interleukin 17 treatment was restarted\u2014without recurrence in the follow-up.<\/jats:p>","DOI":"10.3390\/tropicalmed7100319","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:34:30Z","timestamp":1666312470000},"page":"319","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Visceral Leishmaniasis after Anti-Interleukin 17A (IL-17A) Therapy in a Patient Affected by Psoriatic Arthritis"],"prefix":"10.3390","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3865-9519","authenticated-orcid":false,"given":"Tommaso","family":"Lupia","sequence":"first","affiliation":[{"name":"Unit of Infectious Diseases, Cardinal Massaia, 14100 Asti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Corcione","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy"},{"name":"School of Medicine, Tufts University, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fornari","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Rizzello","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Bosio","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Brusa","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Cardinal Massaia, 14100 Asti, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8338-0130","authenticated-orcid":false,"given":"Francesco Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Unit of Infectious Diseases, Cardinal Massaia, 14100 Asti, Italy"},{"name":"Department of Medical Sciences, Infectious Diseases, University of Turin, 10126 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/exd.12487","article-title":"Cellular sources of IL-17 in psoriasis: A paradigm shift?","volume":"23","author":"Keijsers","year":"2014","journal-title":"Exp. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1038\/ncomms6621","article-title":"The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis","volume":"5","author":"Lande","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_4","first-page":"2379","article-title":"IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani","volume":"119","author":"Pitta","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cellimm.2016.07.004","article-title":"Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines","volume":"309","author":"Banerjee","year":"2016","journal-title":"Cell Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/infdis\/jiu531","article-title":"Interleukin 17A acts synergistically with interferon gamma to promote protection against Leishmania infantum infection","volume":"211","author":"Nascimento","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_7","first-page":"750","article-title":"Leishmaniasis: A review","volume":"26","author":"Arenas","year":"2017","journal-title":"F1000Reserch"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamadermatol.2014.1015","article-title":"Leishmaniasis: A Disease With Many Names","volume":"150","author":"Nazzaro","year":"2014","journal-title":"JAMA Dermatol."},{"key":"ref_9","unstructured":"World Health Organization Regional Office for the Americas (WHO PAHO) (2022, September 24). Leishmaniasis. Washington: WHO PAHO. Available online: https:\/\/www.paho.org\/hq\/dmdocuments\/2017\/2017-cha-leishmaniasis-factsheet-work.pdf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/zph.12477","article-title":"Epidemiological evaluation of Leishmania infantum zoonotic transmission risk in the recently established endemic area of Northwestern Italy","volume":"65","author":"Ferroglio","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jinf.2020.01.019","article-title":"Leishmania infection in psoriasis","volume":"80","author":"Colomba","year":"2020","journal-title":"J. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/1120009X.2017.1323150","article-title":"Visceral leishmaniosis in immunocompromised host: An update and literature review","volume":"29","author":"Pagliano","year":"2017","journal-title":"J. Chemother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jiph.2019.07.026","article-title":"Visceral leishmaniasis in a patient with active HBV\/HDV co-infection","volume":"13","author":"Lupia","year":"2020","journal-title":"J. Infect. Public. Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00403-009-0940-z","article-title":"Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis","volume":"301","author":"Lezama","year":"2009","journal-title":"Arch. Dermatol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3389\/fimmu.2017.01437","article-title":"The Equivocal role of Th17 cells and neutrophils on immunopathogenesis of leishmaniasis","volume":"8","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 Family of Cytokines in Health and Disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: A comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/bjd.18262","article-title":"Cross-sectional screening study for Leishmania DNA and antibodies in biologic-treated patients with psoriasis living in an area endemic for leishmaniasis","volume":"81","author":"Kurizky","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_20","unstructured":"(2022, August 19). Surveillance of Leishmaniasis in the WHO European Region, 2016 and Global Leishmaniasis Surveillance Update, 1998\u20132016. Available online: https:\/\/www.who.int\/publications\/i\/item\/who-wer9340."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s15010-018-1189-2","article-title":"Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs","volume":"46","author":"Maritati","year":"2018","journal-title":"Infection"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","article-title":"Leishmania infections: Molecular targets and diagnosis","volume":"57","author":"Akhoundi","year":"2017","journal-title":"Mol. Asp. Med."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/7\/10\/319\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:58:05Z","timestamp":1760144285000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/7\/10\/319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":22,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["tropicalmed7100319"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed7100319","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}